Swedish Orphan Biovitrum AB (BIOVF)
48.16
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Swedish Orphan Biovitrum EPS Diluted (Quarterly) : 0.3346 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.3346 |
| March 31, 2026 | 0.4127 |
| December 31, 2025 | 0.5677 |
| September 30, 2025 | -0.8823 |
| June 30, 2025 | 0.1896 |
| March 31, 2025 | 0.2363 |
| December 31, 2024 | 0.3734 |
| September 30, 2024 | 0.405 |
| June 30, 2024 | 0.0608 |
| March 31, 2024 | 0.2237 |
| December 31, 2023 | 0.2805 |
| September 30, 2023 | 0.0273 |
| June 30, 2023 | 0.0671 |
| March 31, 2023 | 0.3261 |
| December 31, 2022 | 0.4131 |
| September 30, 2022 | 0.1367 |
| June 30, 2022 | 0.084 |
| March 31, 2022 | 0.1866 |
| December 31, 2021 | 0.4505 |
| September 30, 2021 | 0.1761 |
| June 30, 2021 | 0.1028 |
| March 31, 2021 | 0.2648 |
| December 31, 2020 | 0.5593 |
| September 30, 2020 | 0.1007 |
| June 30, 2020 | 0.094 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.3925 |
| December 31, 2019 | 0.456 |
| September 30, 2019 | 0.1824 |
| June 30, 2019 | 0.1707 |
| March 31, 2019 | 0.325 |
| December 31, 2018 | 0.2324 |
| September 30, 2018 | 0.2456 |
| June 30, 2018 | 0.2784 |
| March 31, 2018 | 0.2243 |
| December 31, 2017 | 0.1515 |
| September 30, 2017 | 0.1408 |
| June 30, 2017 | 0.1064 |
| March 31, 2017 | 0.0803 |
| December 31, 2016 | 0.0285 |
| September 30, 2016 | 0.056 |
| June 30, 2016 | 0.1337 |
| March 31, 2016 | 0.1265 |
| December 31, 2015 | -0.0034 |
| September 30, 2015 | 0.0023 |
| June 30, 2015 | 0.0034 |
| March 31, 2015 | 0.0458 |
| December 31, 2014 | -0.009 |
| September 30, 2014 | 0.0275 |
| June 30, 2014 | 0.0145 |
| March 31, 2014 | -0.1832 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Hansa Biopharma AB | -0.279 |
| BioArctic AB | 0.2615 |
| Diamyd Medical AB | -0.0909 |
| BONESUPPORT HOLDING AB | 0.1309 |
| BioInvent International AB | -0.1982 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 117.25M |
| Revenue (Quarterly) | 837.43M |
| Total Expenses (Quarterly) | 720.28M |
| Enterprise Value | 18.43B |
| Gross Profit Margin (Quarterly) | 61.17% |
| Profit Margin (Quarterly) | 14.00% |
| Earnings Yield | 0.90% |
| Operating Earnings Yield | 5.87% |
| Normalized Earnings Yield | 4.135 |